XBIOTECH INC's ticker is XBIT and the CUSIP is 98400H102. A total of 57 filers reported holding XBIOTECH INC in Q2 2021. The put-call ratio across all filers is 2.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $270,000 | -22.2% | 31,300 | +0.3% | 0.00% | – |
Q4 2021 | $347,000 | -14.1% | 31,200 | 0.0% | 0.00% | – |
Q3 2021 | $404,000 | -21.9% | 31,200 | 0.0% | 0.00% | – |
Q2 2021 | $517,000 | +2.4% | 31,200 | +6.1% | 0.00% | – |
Q1 2021 | $505,000 | -0.8% | 29,400 | -9.5% | 0.00% | – |
Q4 2020 | $509,000 | -22.5% | 32,500 | -5.5% | 0.00% | – |
Q3 2020 | $657,000 | +39.2% | 34,400 | 0.0% | 0.00% | – |
Q2 2020 | $472,000 | +29.3% | 34,400 | 0.0% | 0.00% | – |
Q1 2020 | $365,000 | +27.6% | 34,400 | +124.8% | 0.00% | – |
Q4 2019 | $286,000 | +100.0% | 15,300 | +11.7% | 0.00% | – |
Q3 2019 | $143,000 | -37.3% | 13,700 | -67.9% | 0.00% | – |
Q1 2018 | $228,000 | +35.7% | 42,700 | 0.0% | 0.00% | – |
Q4 2017 | $168,000 | -8.2% | 42,700 | +2.2% | 0.00% | – |
Q3 2017 | $183,000 | -9.0% | 41,800 | -2.3% | 0.00% | – |
Q2 2017 | $201,000 | -34.5% | 42,800 | +130.1% | 0.00% | – |
Q1 2017 | $307,000 | +63.3% | 18,600 | 0.0% | 0.00% | – |
Q4 2016 | $188,000 | -24.8% | 18,600 | 0.0% | 0.00% | – |
Q3 2016 | $250,000 | -30.9% | 18,600 | +7.5% | 0.00% | – |
Q2 2016 | $362,000 | – | 17,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 15,584 | $244,000 | 0.10% |
Thomasville National Bank | 13,650 | $218,000 | 0.03% |
CAAS CAPITAL MANAGEMENT LP | 138,316 | $2,165,000 | 0.02% |
WINTON GROUP Ltd | 13,219 | $207,000 | 0.02% |
Vestcor Inc | 19,371 | $303,000 | 0.01% |
Belvedere Trading LLC | 14,600 | $228,000 | 0.01% |
ALPS ADVISORS INC | 52,398 | $820,000 | 0.01% |
ETF MANAGERS GROUP, LLC | 14,232 | $227,000 | 0.01% |
Belvedere Trading LLC | 6,983 | $109,000 | 0.00% |
SYNOVUS FINANCIAL CORP | 11,796 | $185,000 | 0.00% |